Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erdman, D. M.
Right arrow Articles by Phillips, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erdman, D. M.
Right arrow Articles by Phillips, L. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:9-15, 2002
© 2002 by the American Diabetes Association, Inc.


Clinical Care/Education/Nutrition
Original Article

The Impact of Outpatient Diabetes Management on Serum Lipids in Urban African-Americans With Type 2 Diabetes

Diane M. Erdman, PHARMD1, Curtiss B. Cook, MD2, Kurt J. Greenlund, PHD3, Wayne H. Giles, MD3, Imad El-Kebbi, MD2, Gina J. Ryan, PHARMD4, Daniel L. Gallina, MD2, David C. Ziemer, MD2, Virginia G. Dunbar, BS1 and Lawrence S. Phillips, MD2

1 Grady Health System Atlanta, and the
2 Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine
3 Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, the Centers for Disease Control and Prevention
4 Department of Pharmacy Practice, Mercer University, Atlanta, Georgia

OBJECTIVE—Treating dyslipidemia in diabetic patients is essential, particularly among minority populations with increased risk of complications. Because little is known about the impact of outpatient diabetes management on lipid outcomes, we examined changes in lipid profiles in urban African-Americans who attended a structured diabetes care program.

RESEARCH DESIGN AND METHODS—A retrospective analysis of initial and 1-year follow-up lipid values was conducted among patients selected from a computerized registry of an urban outpatient diabetes clinic. The independent effects of lipid-specific medications, glycemic control, and weight loss on serum total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels were evaluated by analysis of covariance and multiple linear regression.

RESULTS—In 345 patients (91% African-American and 95% with type 2 diabetes), HbA1c decreased from 9.3% at the initial visit to 8.2% at 1 year (P < 0.001); total and LDL cholesterol and triglyceride levels were significantly lower, and HDL cholesterol was higher. After stratifying based on use of lipid-specific therapy, different outcomes were observed. In 243 patients not taking dyslipidemia medications, average total cholesterol, LDL cholesterol, and triglyceride concentrations at 1 year were similar to initial values, whereas in 102 patients receiving pharmacotherapy, these lipid levels were all lower at 1 year relative to baseline (P < 0.001). Mean HDL cholesterol increased regardless of lipid treatment status (P < 0.001). After adjusting for other variables, changes in LDL cholesterol concentration were associated only with use of lipid-specific agents (P = 0.003), whereas improved HbA1c and weight loss had no independent effect. Lipid therapy, improved glycemic control, and weight loss were not independently related to changes in HDL cholesterol and therefore could not account for the positive changes observed. Use of lipid-directed medications, improvement in glycemic control, and weight loss all resulted in significant declines in triglyceride levels but only improved HbA1c and weight loss had an independent effect.

CONCLUSIONS—Among urban African-Americans, diabetes management led to favorable changes in HDL cholesterol and triglyceride levels, but improved glycemic control and weight loss had no independent effect on LDL cholesterol concentration. Initiation of pharmacologic therapy to treat high LDL cholesterol levels should be considered early in the course of diabetes management to reach recommended targets and reduce the risk of cardiovascular complications in this patient population.

Abbreviations: ADA, American Diabetes Association • ANCOVA, analysis of covariance • CVD, cardiovascular disease • HMG, hydroxymethylglutaryl


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Med Care Res RevHome page
M. E. Peek, A. Cargill, and E. S. Huang
Diabetes Health Disparities: A Systematic Review of Health Care Interventions
Med Care Res Rev, October 1, 2007; 64(5_suppl): 101S - 156S.
[Abstract] [PDF]


Home page
Diabetes CareHome page
D. C. Ziemer, K. J. Berkowitz, R. M. Panayioto, I. M. El-Kebbi, V. C. Musey, L. A. Anderson, N. S. Wanko, M. L. Fowke, C. W. Brazier, V. G. Dunbar, et al.
A Simple Meal Plan Emphasizing Healthy Food Choices Is as Effective as an Exchange-Based Meal Plan for Urban African Americans With Type 2 Diabetes
Diabetes Care, June 1, 2003; 26(6): 1719 - 1724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.